Literature DB >> 12623040

Sedations and analgesia in patients undergoing percutaneous transhepatic biliary drainage.

A A Hatzidakis1, E Charonitakis, A Athanasiou, D Tsetis, G Chlouverakis, G Papamastorakis, G Roussopoulou, N C Gourtsoyiannis.   

Abstract

AIM: To present our experience using intravenous sedoanalgesia for percutaneous biliary drainage.
MATERIALS AND METHODS: This study comprised 100 patients, all of whom were continuously monitored [electrocardiogram (ECG), blood pressure, pulse oxymetry] and received an initial dose of 2mg midazolam followed by 0.02 mg fentanyl. Before every anticipated painful procedure, a maintenance dose of 0.01 mg fentanyl was administered. If the procedure continued and the patient became aware, another 1mg midazolam was given. This was repeated if patients felt pain. A total dose of 0.08 mg fentanyl and 7 mg midazolam was never exceeded. Immediately after the procedure, the nurse was asked to evaluate patients' pain score. The patients were asked 3h later to complete a visual 10-degree pain score scale.
RESULTS: The average dose of fentanyl and midazolam was 0.042 mg (0.03-0.08 mg) and 4.28 mg (2-7 mg), respectively. Only one patient recorded the procedure as painful. The scores given by the attending nurse (1-7 points, mean 2.9) correlated well with those given by the patients (1-6 points, mean 2.72). No complications were noted.
CONCLUSION: According to our experience, interventional radiologists practising biliary procedures can administer low doses of midazolam and minimize the doses of fentanyl, without loss of adequate sedation and analgesia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623040     DOI: 10.1053/crad.2002.1128

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  2 in total

1.  Capnography improves detection of apnea during procedural sedation for percutaneous transhepatic cholangiodrainage.

Authors:  Christoph Schlag; Alexandra Wörner; Stefan Wagenpfeil; Eberhard F Kochs; Roland M Schmid; Stefan von Delius
Journal:  Can J Gastroenterol       Date:  2013-10       Impact factor: 3.522

2.  Continuous intravenous versus intermittent bolus midazolam with remifentanil during arteriovenous fistula placement with monitored anesthesia care in chronic renal failure patients: a randomized controlled trial.

Authors:  Gonul Sagiroglu; Ayse Baysal
Journal:  Ann Saudi Med       Date:  2020-06-04       Impact factor: 1.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.